Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)
25 August 2023 (07:30 - 18:30)
Organised by: 

About the speaker

University Hospital Regensburg, Regensburg (Germany)
5 More presentations in this session
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023






